Questions need to be asked regardless of outcome. There is a...

Questions need to be asked regardless of outcome. There is a clear demand just on HC to clear up a large number of issues which have just been met with radio silence. A massive red flag to me is what I view as sweeping under the rug of potentially negative information.

• Where is the peer review (has it been submitted / why isn't it out yet / has it been rejected?)
• R&D day - where are these two new drugs being licenced in? What was the purpose in mentioning this if it wasn't even close? If it didn't end up being the right fit - that's fine, just don't never speak about it again.
• WTF happened with Jeannie?
• Update on 008 - was meant to be provided an update by end of Sep. Is it still even going ahead.
• Update on forecasted trial costs for the whole OA program. Where is funding coming from given the shortfall? Was meant to cost $30m, then $80m, what is it now?
• How much has been spent on external consultants to get OA up to this point? What percent of work is actually done in house versus outsourced?

Could go on - but you get my drift. And didn't someone say PAR has two IR people on the books? Has to be the most cushy job ever.